National Centre for Clinical Research on Emerging Drugs
Impact in
- Virology top 1%
- HIV Research and Treatment
- Hepatology top 2%
- Hepatitis C virus research
Papers in
- Virology 245
- HIV Research and Treatment 241
-
- HIV/AIDS Research and Interventions 340
- HIV/AIDS drug development and treatment 174
- Top scholars
- Wayne HallLouisa DegenhardtJohn KaldorMatthew LawDavid A. CooperGregory J. DoreAndrew CarrRichard P. Mattick
- Journals
- Drug and Alcohol Review (168 papers)Addiction (142 papers)AIDS (118 papers)Sexual Health (69 papers)The Medical Journal of Australia (64 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
National Centre for Clinical Research on Emerging Drugs
1.8k papers receiving 85.3k citations
Peers
Comparison fields: 5 of 227
- Virology 13.7k
- Hepatology 11.9k
- Emergency Medicine 12.0k
- Infectious Diseases 23.4k
- Epidemiology 33.9k
Countries citing scholars working at National Centre for Clinical Research on Emerging Drugs
This map shows the geographic impact of research produced by authors working at National Centre for Clinical Research on Emerging Drugs. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at National Centre for Clinical Research on Emerging Drugs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites National Centre for Clinical Research on Emerging Drugs more than expected).
Fields of papers published by authors at National Centre for Clinical Research on Emerging Drugs
This network shows the impact of papers affiliated with National Centre for Clinical Research on Emerging Drugs at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with National Centre for Clinical Research on Emerging Drugs at the time of their publication.
About National Centre for Clinical Research on Emerging Drugs
In recent decades, authors affiliated with National Centre for Clinical Research on Emerging Drugs have published 2.2k papers, which have received a total of 117.5k indexed citations . Scholars at this organization have produced 245 papers in Virology, 472 papers in Infectious Diseases, 176 papers in Hepatology, 635 papers in Epidemiology and 119 papers in Emergency Medicine on the topics of HIV/AIDS Research and Interventions (340 papers), HIV, Drug Use, Sexual Risk (282 papers), HIV Research and Treatment (241 papers), HIV/AIDS drug development and treatment (174 papers), Hepatitis C virus research (172 papers), Substance Abuse Treatment and Outcomes (163 papers), Opioid Use Disorder Treatment (112 papers) and Adolescent Sexual and Reproductive Health (109 papers). Their work is cited by papers focused on Virology (13.7k citations), Hepatology (11.9k citations), Emergency Medicine (12.0k citations), Infectious Diseases (23.4k citations) and Epidemiology (33.9k citations). Authors at National Centre for Clinical Research on Emerging Drugs collaborate with scholars in Australia, United States and United Kingdom and have published in prestigious journals including Drug and Alcohol Review, Addiction, AIDS, Sexual Health and The Medical Journal of Australia. Some of National Centre for Clinical Research on Emerging Drugs's most productive authors include Wayne Hall, Louisa Degenhardt, John Kaldor, Matthew Law, David A. Cooper, Gregory J. Dore, Andrew Carr, Richard P. Mattick, Andrew E. Grulich and Susan Kippax.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.